The Induction of IL-6 by NF-kB in PBMC in OSA
The study, sponsored by National Taiwan University Hospital, investigates the role of IL-6 and NF-kB in patients with severe obstructive sleep apnea syndrome (OSAS). Given the increasing recognition of OSAS as a significant risk factor for cardiovascular diseases, the findings could have substantial implications for therapeutic interventions, particularly in the development of anti-inflammatory strategies. The potential market for CPAP devices and related therapies is significant, especially as awareness of OSAS and its comorbidities grows. Companies focusing on sleep medicine and inflammatory pathways may find strategic opportunities for collaboration or acquisition based on the outcomes of this study.
Indication: Sleep Apnea, Obstructive
Modality: medical device
Target: IL-6 mRNA expression and NF-kB activation in peripheral blood monocytes
Sponsor: National Taiwan University Hospital
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 11, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: IL-6 mRNA expression and NF-kB activation in peripheral blood monocytes
View original source fields
Condition raw: Sleep Apnea, Obstructive
Condition normalized: Sleep Apnea, Obstructive
Modality raw: medical device
Modality normalized: medical device
Target raw: IL-6 mRNA expression and NF-kB activation in peripheral blood monocytes
Target normalized: IL-6 mRNA expression and NF-kB activation in peripheral blood monocytes